Literature DB >> 18830187

Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.

Lukasz Krakowczyk1, Joanna K Strzelczyk, Brygida Adamek, Marzena Zalewska-Ziob, Jerzy Arendt, Stanisław Półtorak, Bogusław Maciejewski, Andrzej Wiczkowski.   

Abstract

BACKGROUND: Colorectal cancer, one of the most aggressive cancers, occurs with a high incidence in most countries. The usual treatment is surgery and subsequent chemotherapy and radiotherapy. Cancer development and progression is dictated by series of alterations in genes such as tumor suppressor genes, DNA repair genes, oncogenes and others. In colorectal carcinogenesis disturbances different from mutations called an epigenetic regulation are also taken into consideration. Epigenetics is defined as a modifications of the genome, heritable during cell division, which do not involve a change in the DNA sequence. In our study we analyzed methylation of CpG islands in the MGMT and p16 genes in sporadic colorectal cancers and normal corresponding colonic mucosa. MATERIAL/
METHODS: Fresh tissue samples were obtained from 68 patients (age of 23 to 81 years) with primary colorectal adenocarcinoma and corresponding normal tissues. We used methylation-specific polymerase chain reaction (MSP) for analysis of the methylation status of MGMT and p16.
RESULTS: Methylation of MGMT and p16 was detected in 59% and 53% of tumors, respectively. In corresponding normal colonic mucosa methylation of MGMT was detected in 20% and p16 in 18%. The normal colon mucosa obtained from younger patients (age of <65 years) showed less methylation frequency as compared with the normal mucosa from the older ones (age of >65 years).
CONCLUSIONS: The older age and female gender are generally associated with higher methylation levels for most CpG islands in normal colonic mucosa. These results indicate that MGMT and/or p16 aberrant methylation may play an important role in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830187

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  9 in total

Review 1.  Sex-specific aspects of tumor therapy.

Authors:  Kerstin Borgmann; Ekkehard Dikomey; Cordula Petersen; Petra Feyer; Ulrike Hoeller
Journal:  Radiat Environ Biophys       Date:  2009-02-26       Impact factor: 1.925

2.  Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism.

Authors:  Fabio Coppedè; Francesca Migheli; Angela Lopomo; Alessandra Failli; Annalisa Legitimo; Rita Consolini; Gabriella Fontanini; Elisa Sensi; Adele Servadio; Massimo Seccia; Giuseppe Zocco; Massimo Chiarugi; Roberto Spisni; Lucia Migliore
Journal:  Epigenetics       Date:  2014-01-31       Impact factor: 4.528

3.  KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.

Authors:  Shao-Qin Chen; Zhi-Hua Chen; Su-Yong Lin; Qi-Bao Dai; Leng-Xi Fu; Rui-Qing Chen
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Ageing, chronic alcohol consumption and folate are determinants of genomic DNA methylation, p16 promoter methylation and the expression of p16 in the mouse colon.

Authors:  Julia Sauer; Hyeran Jang; Ella M Zimmerly; Kyong-Chol Kim; Zhenhua Liu; Aurelie Chanson; Donald E Smith; Joel B Mason; Simonetta Friso; Sang-Woon Choi
Journal:  Br J Nutr       Date:  2010-03-08       Impact factor: 3.718

5.  Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.

Authors:  Chen-Guo Zheng; Chun Jin; Le-Chi Ye; Nian-Zhao Chen; Zong-Jing Chen
Journal:  Tumour Biol       Date:  2015-02-27

6.  Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.

Authors:  Vanessa Deschoolmeester; Veerle Van Marck; Marc Baay; Christine Weyn; Peter Vermeulen; Eric Van Marck; Filip Lardon; Veronique Fontaine; Jan B Vermorken
Journal:  BMC Cancer       Date:  2010-03-26       Impact factor: 4.430

7.  A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.

Authors:  Xin Zhao; Tao Song; Zhoukang He; Lian Tang; Yimin Zhu
Journal:  Med Oncol       Date:  2009-10-06       Impact factor: 3.064

8.  Promoter and histone methylation and p16(INK4A) gene expression in colon cancer.

Authors:  Ebru Esin Yoruker; Ufuk Mert; Dursun Bugra; Sumer Yamaner; Nejat Dalay
Journal:  Exp Ther Med       Date:  2012-08-24       Impact factor: 2.447

9.  Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.

Authors:  Fucheng Cai; Xiyue Xiao; Xun Niu; Hao Shi; Yi Zhong
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.